|
Membership Qualifications
Membership
in ISIA is available to companies actively
engaged in, or associated with, the collection,
sale, distribution, and processing of serum,
as defined in Article 2, Section 2.1 of the
ISIA bylaws.
Regular Membership
Regular
Membership is available to companies and groups
actively engaged in the collection, sale,
distribution, and processing of serum as defined
in Article 2, Section 2.1. Regular Members
have voting rights (one (1) vote per Member
Company). Paid membership allows for up to
two (2) participant Members at identified
ISIA meetings and functions, a primary
and alternate. While each  member holding regular membership
will be eligible to serve as directors and
officers, only the designated primary member
will be allowed to vote.
Additionally, employees of member companies
can attend ISIA meetings as invited. These
members do NOT have voting rights nor can
they serve as directors or officers. Planned
participation in meetings will be indicated
in writing in advance. A nominal meeting fee
will be charged to cover associated costs.
Associate Membership
Associate
Membership is available to individuals, companies,
universities, research institutions, government
agencies and other organizations engaged in
ancillary activities and in supportive functions
and not actively engaged in the collection,
sale, distribution, and processing of serum
as defined in Article 2, Section 2.1. Associate
Members are limited to attendance at ISIA
meetings as invited and a nominal meeting fee
will be charged to cover associated costs.
Associate Members do not have voting rights,
and they and their employees are not eligible
to serve as directors or officers.
Dues Structure
At the Annual Meeting in 2007 the Association approved a wholly apportioned approach to dues assessment in which each regular member pays a set percentage of their self-reported revenues from serum. This new structure requires that companies report revenues for the preceding fiscal year as defined by the following statements:
- This figure is to be derived only from end-user revenues for each member group
or company. Internal transfers should not be included.
- Each member should draw this figure from their most recent audited financials
- Each member should include only revenue generated from the sales of animal
blood products for use in life science research, diagnostic kit production and the
manufacturing of biopharmaceutical products and vaccines.
The Board of directors has approved a floor level or dues for the smallest member companies and a cap level for the largest companies The ISIA has contracted with Maloney & Associates PLLC, an independent, third-party bookkeeper to collect this revenue data from all members, calculate proportionate dues, generate and distribute invoices to each member, and collect monies for aggregate transfer into the ISIA accounts. In this way, no-one within the Association will have any knowledge of the numbers submitted
For a full listing see the News section
|
